Cited 0 times in Scipus Cited Count

Change of Quality of Life in Children with ADHD after 12 Weeks OROS-Methylphenidate Treatment

DC Field Value Language
dc.contributor.author김, 형인-
dc.contributor.author김, 붕년-
dc.contributor.author조, 수철-
dc.contributor.author신, 민섭-
dc.contributor.author유, 희정-
dc.contributor.author김, 재원-
dc.contributor.author김, 지훈-
dc.contributor.author손, 정우-
dc.contributor.author신, 윤미-
dc.contributor.author정, 운선-
dc.contributor.author한, 덕현-
dc.date.accessioned2014-03-19T05:48:08Z-
dc.date.available2014-03-19T05:48:08Z-
dc.date.issued2012-
dc.identifier.issn1225-729X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/9751-
dc.description.abstractObjectives : The aim of this study is to investigate the effectiveness of treatment with osmotic-release oral system methylphenidate (OROS-MPH) on quality of life (QOL) in children with attention-deficit hyperactivity disorder (ADHD). Another aim is to assess the relationship between change in QOL and other factors including children’s symptoms and academic performance or parents’ depression and parenting stress.



Methods : A total of 111 medication-naive children with ADHD in a multicenter, open-label, 12-week trial of OROS-MPH completed an evaluation using diverse rating scales at two time points; at baseline and after 12 weeks of treatment. Scales for investigation of children included the Parent Report Form-Children’s Health and Illness Profile-Children’s Edition (PRF-CHIP-CE) on QOL, the ADHD Rating Scale-IV on symptoms, and the Academic Performance Rating Scale (APRS). The Beck Depression Inventory and Parenting Stress Index were used for assessment of their parents.



Results : Total scores for mean PRF-CHIP-CE increased from at baseline to after 12 weeks of treatment (p<.001). The change of APRS showed the strongest correlation with the increment of PRF-CHIP-CE scores (Pearson coefficient=0.561, p<.001), even after controlling for other factors (partial correlation coefficient=0.420, p<.001).



Conclusion : Treatment with MPH-OROS results in improvement of QOL in children with ADHD in Korea. The advance in academic performance plays a key role in this change of QOL.
-
dc.language.isoko-
dc.titleChange of Quality of Life in Children with ADHD after 12 Weeks OROS-Methylphenidate Treatment-
dc.title.alternative12주 OROS-Methylphenidate 약물 치료 후 ADHD 아동의 삶의 질 변화-
dc.typeArticle-
dc.identifier.urlhttp://acoms.kisti.re.kr/journal.do?method=viewFullTextArchive&journalSeq=J000026&menuId=0202&introMenuId=0202-
dc.subject.keyword삶의 질-
dc.subject.keyword메틸페니데이트-
dc.subject.keyword주의력결핍 과잉행동장애-
dc.subject.keywordQuality of Life-
dc.subject.keywordMethylphenidate-
dc.subject.keywordAttention-Deficit Hyperactivity Disorder-
dc.contributor.affiliatedAuthor신, 윤미-
dc.type.localJournal Papers-
dc.citation.titleJournal of the Korean Academy of child and adolescent psychiatry-
dc.citation.volume23-
dc.citation.number3-
dc.citation.date2012-
dc.citation.startPage103-
dc.citation.endPage108-
dc.identifier.bibliographicCitationJournal of the Korean Academy of child and adolescent psychiatry, 23(3). : 103-108, 2012-
dc.identifier.eissn2233-9183-
dc.relation.journalidJ11225729X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Psychiatry & Behavioural Sciences
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse